kabutan

Fuji Pharma, Oct-Jun (Cumulative 3Q) Ordinary Profit Increases by 6%

Thu Aug 7, 2025 4:30 pm JST Earnings

4554 Fuji Pharma Co.,Ltd. 【J-GAAP】

Earnings Report

Fuji Pharma Co.,Ltd. <4554> [TSE Prime] announced its financial results after the market closed on August 7th (16:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending September 2025 (October 2024 to June 2025) increased 6.4% from the same period last year, reaching 3.15 billion yen. However, Progress toward the full-year plan of 4.68 billion yen was 67.5%, also falling below the five-year average of 82.6%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the July to September period (4Q) is expected to grow 3.0% from the same period last year, reaching 1.52 billion yen.

In the most recent three-month period, from April to June (3Q), the consolidated ordinary profit grew 18.2% from the same period last year, reaching 0.94 billion yen. The operating profit margin improved from 6.6% in the same period last year to 8.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Oct - Jun, 2022 29,482 2,403 2,741 1,982 81.6 60.7 Aug 8, 2023 J-GAAP
Oct - Jun, 2023 33,155 2,215 2,967 4,910 202.0 66.7 Aug 8, 2024 J-GAAP
Oct - Jun, 2024 36,954 3,367 3,157 1,830 75.1 67.5 Aug 7, 2025 J-GAAP
YoY +11.5% +52.0% +6.4% -62.7% -62.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 24,750 2,437 2,280 1,889 77.7 22.50 Nov 12, 2024 J-GAAP
Apr - Sep, 2025 Guidance 29,265 2,545 2,471 2,093 85.6 25.50 May 8, 2025 J-GAAP
YoY +18.2% +4.4% +8.4% +10.8% +10.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2023 40,889 3,858 4,519 3,435 141.4 37 Nov 9, 2023 J-GAAP
Sep, 2024 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
Sep, 2025 Guidance 53,360 4,850 4,680 3,380 138.2 45.50 Nov 12, 2024 J-GAAP
YoY +15.7% +25.0% +5.3% -45.0% -45.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 11,767 772 802 653 26.9 6.6 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 12,983 1,665 1,478 1,236 50.9 12.8 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 13,000 1,252 1,376 991 40.8 9.6 Feb 6, 2025 J-GAAP
Jan - Mar, 2025 11,095 1,053 833 296 12.2 9.5 May 8, 2025 J-GAAP
Apr - Jun, 2025 12,859 1,062 948 543 22.3 8.3 Aug 7, 2025 J-GAAP
YoY +9.3% +37.6% +18.2% -16.8% -17.1%

Related Articles